PD-E2: a nano-scaled delivery for estradiol to decrease uterus damage and increase bone mineral density

In: Journal of Materials Chemistry B · 2025 · vol. 13(23) , pp. 6679–6688 · doi:10.1039/d4tb02764g · PMID:40365736 · W4409992926
article OA: closed CC0

Abstract

PD-E2 was capable of simultaneously blocking bone loss and downregulating the expression of ALP in the serum, which made serum ALP a potential biomarker for monitoring the bone health of menopause women clinically.
Full text 1,247 characters · extracted from oa-doi-fallback · click to expand
PD-E2: a nano-scaled delivery for estradiol to decrease uterus damage and increase bone mineral density† Abstract It is well known that a specific application of 17β-estradiol (E2) is in hormone replacement therapy (HRT), but it is capable of inducing uterine gland cysts. However, the concentration of E2 that causes uterine gland cysts and bone loss remains unknown. To better understand this, we used an ovariectomized (OVX) mouse as the animal model and administered poly-α,β-DL-aspartyl-Lys-coupled E2 (PD-E2) as the bone targeting agent. HPLC-FT-MS analysis showed that the amounts of E2 in the uterus and the femurs of the OVX mice treated with 2.3 μmol kg−1 per day of E2 were 0.62 ± 0.15 ng g−1 and 0.31 ± 0.09 ng g−1, respectively, while the amounts of E2 in the uterus and the femurs of the OVX mice treated with 10 nmol kg−1 per day of PD-E2 were 0 ± 0 ng g−1 and 1.11 ± 0.27 ng g−1, respectively. The data suggested that if the amount of E2 in the uterus was equal to 0.62 ± 0.15 ng g−1, the uterine gland will form cysts, and if the amount of E2 in the femurs was less than 0.31 ± 0.09 ng g−1, the bone loss will be significant. Furthermore, the nano-scaled PD-E2 agent reported in this study provides an innovative strategy for HRT.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (23)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK